WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · HB 310

Legislative bill overview

HB 310 relates to opioid antagonists (medications like naloxone that reverse opioid overdoses) in Hawaii, though the specific provisions are not detailed in the action summary provided. The bill has been referred to Education, Health, and Finance committees, suggesting it may address access, distribution, training, or funding related to these life-saving medications.

Why is this important

Opioid overdose deaths remain a significant public health crisis. Legislation expanding access to opioid antagonists—through pharmacy distribution, standing orders, harm reduction programs, or public access—can directly reduce fatal overdoses and represents a proven intervention strategy supported by public health organizations.

Potential points of contention

  • Cost and funding allocation: Finance committee involvement suggests debate over state funding mechanisms and who bears costs (government, pharmacies, insurance)
  • Distribution model and liability: Disagreement over whether antagonists should be available without prescription, through pharmacies, or in public spaces, plus questions about manufacturer/provider liability
  • Integration with education and prevention: Education committee referral may indicate tension between treatment access and prevention-focused approaches, or concerns about implementation in schools

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.